LV ENDOCRINE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LV ENDOCRINE
Largest movements
- Cash +€64,767
up €64,767 (+47.4%), from €136,660 to €201,427
mainly Net result for the year (+€67,205) and Depreciation (+€1,650)
- Profit (loss) carried forward +€67,205
new in 2025: €67,205
- Tax, wage and social debts -€2,167
down €2,167 (-4.9%), from €44,296 to €42,129
- Gross operating margin +€36,085
up €36,085 (+58.9%), from €61,218 to €97,303
- Taxes +€6,812
up €6,812 (+38.6%), from €17,659 to €24,470
- Depreciation -€1,875
down €1,875 (-53.2%), from €3,525 to €1,650
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €141,140 | €204,571 | +€63,431 | +44.9% |
| Fixed assets | 21/28 | €4,230 | €2,580 | -€1,650 | -39.0% |
| Tangible fixed assets | 22/27 | €4,230 | €2,580 | -€1,650 | -39.0% |
| Plant, machinery and equipment | 23 | €375 | - | -€375 | |
| Furniture and vehicles | 24 | €3,855 | €2,580 | -€1,275 | -33.1% |
| Current assets | 29/58 | €136,910 | €201,991 | +€65,080 | +47.5% |
| Cash at bank and in hand | 54/58 | €136,660 | €201,427 | +€64,767 | +47.4% |
| Deferred charges and accrued income | 490/1 | €250 | €564 | +€314 | +125.2% |
| Total equity and liabilities | 10/49 | €141,140 | €204,571 | +€63,431 | +44.9% |
| Equity | 10/15 | €91,879 | €159,085 | +€67,205 | +73.1% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €90,879 | €90,879 | = | 0.0% |
| Distributable reserves | 133 | €90,879 | €90,879 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €67,205 | +€67,205 | |
| Amounts payable | 17/49 | €49,261 | €45,486 | -€3,775 | -7.7% |
| Amounts payable within one year | 42/48 | €49,261 | €45,486 | -€3,775 | -7.7% |
| Trade debts | 44 | €952 | €613 | -€338 | -35.6% |
| Suppliers | 440/4 | €952 | €613 | -€338 | -35.6% |
| Taxes, remuneration and social security | 45 | €44,296 | €42,129 | -€2,167 | -4.9% |
| Taxes | 450/3 | €44,296 | €42,129 | -€2,167 | -4.9% |
| Other amounts payable | 47/48 | €4,013 | €2,743 | -€1,269 | -31.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,525 | €1,650 | -€1,875 | -53.2% |
| Other operating charges | 640/8 | €1,152 | €295 | -€857 | -74.4% |
| Gross operating margin | 9900 | €61,218 | €97,303 | +€36,085 | +58.9% |
| Operating profit (loss) | 9901 | €56,541 | €95,359 | +€38,818 | +68.7% |
| Financial income | 75/76B | €30 | - | -€30 | |
| Recurring financial income | 75 | €30 | - | -€30 | |
| Financial charges | 65/66B | €3,632 | €3,683 | +€51 | +1.4% |
| Recurring financial charges | 65 | €3,632 | €3,683 | +€51 | +1.4% |
| Profit (loss) for the period before taxes | 9903 | €52,939 | €91,676 | +€38,737 | +73.2% |
| Income taxes | 67/77 | €17,659 | €24,470 | +€6,812 | +38.6% |
| Profit (loss) for the period | 9904 | €35,280 | €67,205 | +€31,925 | +90.5% |
| Profit (loss) for the period to be appropriated | 9905 | €35,280 | €67,205 | +€31,925 | +90.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.